Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BioMensio

Financiado

Cerrado

BioMensio mobile biosensing platform the first truly palm sized and accurate di...

BioMensio mobile biosensing platform the first truly palm sized and accurate digital multi drug test In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxicat... ver más

31/03/2022

BIOMENSIO OY

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

BIOMENSIO OY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-03-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 61% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

BIOMENSIO OY

2.49M€ | Lider

ENERGIAS RENOVABLES E INNOVA...

417.60K€ | Participante

Proyectos interesantes

Stellar i-ris

Medical Technol...

Cybersecurity

3M€ Cerrado

DrugStop

Medical Technol...

Cybersecurity

71K€ Cerrado

TEC2013-44817-R

Medical Technol...

Nanotechnology

133K€ Cerrado

DESARROLLO TECNOLÓGICO DE UN KIT PARA LA DETE...

Medical Technol...

Data Science

300K€ Cerrado

DESARROLLO TECNOLÓGICO DE UN NOVEDOSO KIT DE...

Medical Technol...

Data Science

511K€ Cerrado

IMPETUS

Medical Technol...

Software

6M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 37 meses Fecha Inicio: 2019-02-27
Fecha Fin: 2022-03-31

Líder del proyecto

BIOMENSIO OY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs. BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology. BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores